Peking University First Hospital
Clinical trials sponsored by Peking University First Hospital, explained in plain language.
-
New drug hope for painful hand and foot pustules
Disease control TerminatedThis trial tested the drug deucravacitinib in people with moderate-to-severe palmoplantar pustulosis, a skin condition causing painful pustules on the palms and soles. The study planned to enroll 25 participants who would take the drug daily for 16 weeks, but it was terminated ea…
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug targets hidden pain after keyhole surgery
Symptom relief TerminatedThis study tested a drug called anrikefon for treating deep internal pain after laparoscopic (keyhole) surgery. It was given through a pump that patients could control. The trial was stopped early and included only 13 adults. The goal was to see if anrikefon could better manage t…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Anesthesia study seeks safer surgery for heart and brain
Knowledge-focused TerminatedThis study looked at 50,000 adults who had non-cardiac surgery under general anesthesia. Researchers wanted to see if the type of anesthesia used was linked to serious heart or brain problems after surgery. The goal was to find safer ways to give anesthesia.
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC